| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12015-018-9857-2 |
| P698 | PubMed publication ID | 30345477 |
| P50 | author | Vânia Leal | Q92459185 |
| Bárbara Oliveiros | Q51401127 | ||
| Natália António | Q53031619 | ||
| P2093 | author name string | Sónia Silva | |
| Carlos Fontes Ribeiro | |||
| P2860 | cites work | Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand | Q24644662 |
| Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization | Q24673319 | ||
| Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease | Q26770056 | ||
| Technologies for Single-Cell Isolation | Q26799345 | ||
| Current therapy of non-ST-elevation acute coronary syndromes | Q26999720 | ||
| AC133, a novel marker for human hematopoietic stem and progenitor cells | Q28115893 | ||
| CD105 is important for angiogenesis: evidence and potential applications | Q28207439 | ||
| Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood | Q28269379 | ||
| Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
| Mechanisms of angiogenesis and arteriogenesis | Q29617257 | ||
| Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
| Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk | Q30495462 | ||
| Flow cytometry and cell sorting | Q30833623 | ||
| Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. | Q53662576 | ||
| Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. | Q54693974 | ||
| Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction | Q57589498 | ||
| CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells | Q58297995 | ||
| Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study | Q58314248 | ||
| Endothelial Colony Forming Capacity is Related to C-Reactive Protein Levels in Healthy Subjects | Q59136002 | ||
| Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: Time-course after acute myocardial infarction and stroke | Q61771939 | ||
| Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors | Q70012827 | ||
| Endothelial progenitor cells | Q72992259 | ||
| CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation | Q73802345 | ||
| Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells | Q74033028 | ||
| Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo | Q74570325 | ||
| Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization | Q77323614 | ||
| Characterisation of progenitor cells in human atherosclerotic vessels | Q79759754 | ||
| SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells | Q80396461 | ||
| Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries | Q80794984 | ||
| Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease | Q81072687 | ||
| Endothelial colony forming units: are they a reliable marker of endothelial progenitor cell numbers? | Q81334434 | ||
| Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease | Q81432945 | ||
| Morphological and phenotypical characterization of human endothelial progenitor cells in an early stage of differentiation | Q81700977 | ||
| CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities | Q82388674 | ||
| Vascular wall resident progenitor cells: a source for postnatal vasculogenesis | Q82766257 | ||
| Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis | Q83168031 | ||
| The human coronary collateral circulation | Q84376435 | ||
| Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing | Q84594884 | ||
| The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease | Q84627179 | ||
| A novel and feasible way to cultivate and purify endothelial progenitor cells from bone marrow of children with congenital heart diseases | Q84774721 | ||
| Acute Myocardial Infarction | Q88136896 | ||
| Acute coronary syndromes | Q88960063 | ||
| Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective | Q30884351 | ||
| Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells | Q33450208 | ||
| EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy | Q33558915 | ||
| Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress | Q33572269 | ||
| Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol | Q33745065 | ||
| Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. | Q33847880 | ||
| Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation | Q33857901 | ||
| Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
| Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors | Q33887795 | ||
| Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function | Q33941111 | ||
| Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential | Q34097326 | ||
| Postnatal vasculogenesis | Q34133858 | ||
| Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. | Q34286784 | ||
| Vasculogenesis | Q34387300 | ||
| Concise review: evidence for CD34 as a common marker for diverse progenitors | Q34402307 | ||
| Endothelial progenitor cells as factors in neovascularization and endothelial repair | Q34444790 | ||
| A common precursor for hematopoietic and endothelial cells. | Q34452940 | ||
| Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study | Q34467988 | ||
| Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals | Q34575418 | ||
| Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells | Q34843244 | ||
| Hemangioblasts, angioblasts, and adult endothelial cell progenitors | Q35618193 | ||
| CD34 marks angiogenic tip cells in human vascular endothelial cell cultures | Q35742932 | ||
| Endothelial Progenitor Cells Predict Cardiovascular Events after Atherothrombotic Stroke and Acute Myocardial Infarction. A PROCELL Substudy. | Q35762330 | ||
| MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell | Q35886676 | ||
| Endothelial progenitor cells in atherosclerosis | Q36011477 | ||
| Mobilizing endothelial progenitor cells | Q36012003 | ||
| Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry | Q36019443 | ||
| Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. | Q36055443 | ||
| Hypoxia-induced angiogenesis: good and evil | Q36137705 | ||
| Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? | Q36328639 | ||
| Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice | Q36545262 | ||
| Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases | Q36603898 | ||
| Clinical Application of Endothelial Progenitor Cell: Are We Ready? | Q36721957 | ||
| Endothelial progenitor cell: a blood cell by many other names may serve similar functions | Q36991096 | ||
| Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. | Q37076991 | ||
| Gender and Endothelial Progenitor Cell Number in Middle-Aged Adults. | Q37085662 | ||
| Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult | Q37366772 | ||
| Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells | Q37427910 | ||
| Hemato-vascular origins of endothelial progenitor cells? | Q37691004 | ||
| The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development | Q37734546 | ||
| Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives. | Q37762507 | ||
| Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells | Q37820212 | ||
| Human endothelial progenitor cells | Q38023863 | ||
| Influence of growth factors and cytokines on angiogenic function of endothelial progenitor cells: a review of in vitro human studies | Q38202978 | ||
| C-reactive protein and inflammation: conformational changes affect function. | Q38514723 | ||
| Levels of Circulating Progenitor Cells, Cardiovascular Outcomes and Death: A Meta-Analysis of Prospective Observational Studies | Q38881908 | ||
| Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke | Q39275184 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Endothelial progenitor cells and left ventricle function in patients with acute myocardial infarction: potential therapeutic considertions | Q39865650 | ||
| The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression | Q39956710 | ||
| Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
| Flow cytometric analysis for reproductive biology | Q40771558 | ||
| CD34: structure, biology, and clinical utility. | Q40938642 | ||
| Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol. | Q41069524 | ||
| Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues | Q41342478 | ||
| Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis | Q42199433 | ||
| The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis | Q42411644 | ||
| Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction | Q42439863 | ||
| Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells | Q42498432 | ||
| The Role of Endothelial Progenitor Cells in Postnatal Vasculogenesis: Implications for Therapeutic Neovascularization and Wound Healing | Q42565183 | ||
| VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells | Q42677798 | ||
| Potential mechanism for endothelial progenitor cell therapy in acute myocardial infarction: Activation of VEGF- PI3K/Akte-NOS pathway | Q43516278 | ||
| Mobilization of endothelial progenitor cells in patients with acute myocardial infarction | Q43636896 | ||
| Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. | Q43658679 | ||
| Forearm ischemia decreases endothelial colony-forming cell angiogenic potential | Q43744046 | ||
| Three specific antigens to isolate endothelial progenitor cells from human liposuction material. | Q44691187 | ||
| Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-reactive protein and endothelial progenitor cells after acute coronary syndrome. | Q46000079 | ||
| Active Stromal Cell-Derived Factor 1α and Endothelial Progenitor Cells are Equally Increased by Alogliptin in Good and Poor Diabetes Control | Q47131763 | ||
| Low angiogenic potency induced by the implantation of ex vivo expanded CD117(+) stem cells | Q47341295 | ||
| Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators | Q47433005 | ||
| Substance P enhances EPC mobilization for accelerated wound healing. | Q48265780 | ||
| The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. | Q51168559 | ||
| Influence of preinfarction angina on the release kinetics of endothelial progenitor cells and cytokines during the week after infarction. | Q51575571 | ||
| Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. | Q52572477 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute coronary syndrome | Q266018 |
| P304 | page(s) | 35-47 | |
| P577 | publication date | 2019-02-01 | |
| P1433 | published in | Stem Cell Reviews and Reports | Q7607285 |
| P1476 | title | Intrinsic Vascular Repair by Endothelial Progenitor Cells in Acute Coronary Syndromes: an Update Overview | |
| P478 | volume | 15 |
Search more.